The Lancet19h
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial
The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...
Technology Networks20h
COVID-19 Boosters Protect Immunocompromised People From Breakthrough Infections
New research findings provide evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...
MPR4h
FDA Approves Freeze-Dried Formulation of Mpox, Smallpox Vaccine
The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.
Hosted on MSN10d
Antibody-based therapy is several steps closer to treat lethal mucormycosis
Although both protect from infection, the humanized antibody reduces immunogenicity and enhances therapeutic effect when used in humans, a major translational step. Early tests show that VX-01 is safe ...
EurekAlert!1d
COVID-19 boosters help avoid breakthrough infections in immunocompromised people, McGill-led study finds
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The ...
Medscape8d
Bivalent RSV Vaccine Shows Sustained Efficacy and Safety Through Two Seasons in Older Adults
The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing ...
CDI Labs Launches Technology Access Program for Custom PhIP-Seq Libraries for Massively Multiplexed Analysis of Serum Antibodies
CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today ...
health.economictimes.indiatimes9d
Antibody-based therapy several notches closer to treat lethal mucormycosis: Study
Although both protect from infection, the humanized antibody reduces immunogenicity and enhances therapeutic effect when used in humans, a major translational step. Early tests show that VX-01 is ...